000091678902/282024Q2FALSE00009167892023-03-012023-08-310000916789dei:OtherAddressMember2023-03-012023-08-3100009167892023-09-28xbrli:shares00009167892023-08-31iso4217:USD00009167892023-02-28iso4217:USDxbrli:shares00009167892023-06-012023-08-3100009167892022-06-012022-08-3100009167892022-03-012022-08-310000916789us-gaap:CommonStockMember2022-02-280000916789us-gaap:AdditionalPaidInCapitalMember2022-02-280000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-02-280000916789us-gaap:RetainedEarningsMember2022-02-2800009167892022-02-280000916789us-gaap:RetainedEarningsMember2022-03-012022-05-3100009167892022-03-012022-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-012022-05-310000916789us-gaap:CommonStockMember2022-03-012022-05-310000916789us-gaap:AdditionalPaidInCapitalMember2022-03-012022-05-310000916789us-gaap:CommonStockMember2022-05-310000916789us-gaap:AdditionalPaidInCapitalMember2022-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-05-310000916789us-gaap:RetainedEarningsMember2022-05-3100009167892022-05-310000916789us-gaap:RetainedEarningsMember2022-06-012022-08-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-012022-08-310000916789us-gaap:CommonStockMember2022-06-012022-08-310000916789us-gaap:AdditionalPaidInCapitalMember2022-06-012022-08-310000916789us-gaap:CommonStockMember2022-08-310000916789us-gaap:AdditionalPaidInCapitalMember2022-08-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-08-310000916789us-gaap:RetainedEarningsMember2022-08-3100009167892022-08-310000916789us-gaap:CommonStockMember2023-02-280000916789us-gaap:AdditionalPaidInCapitalMember2023-02-280000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-02-280000916789us-gaap:RetainedEarningsMember2023-02-280000916789us-gaap:RetainedEarningsMember2023-03-012023-05-3100009167892023-03-012023-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-012023-05-310000916789us-gaap:CommonStockMember2023-03-012023-05-310000916789us-gaap:AdditionalPaidInCapitalMember2023-03-012023-05-310000916789us-gaap:CommonStockMember2023-05-310000916789us-gaap:AdditionalPaidInCapitalMember2023-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-05-310000916789us-gaap:RetainedEarningsMember2023-05-3100009167892023-05-310000916789us-gaap:RetainedEarningsMember2023-06-012023-08-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-012023-08-310000916789us-gaap:CommonStockMember2023-06-012023-08-310000916789us-gaap:AdditionalPaidInCapitalMember2023-06-012023-08-310000916789us-gaap:CommonStockMember2023-08-310000916789us-gaap:AdditionalPaidInCapitalMember2023-08-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-08-310000916789us-gaap:RetainedEarningsMember2023-08-31hele:segment0000916789hele:CurlsmithMember2022-04-222022-04-2200009167892021-06-072021-06-070000916789hele:LatinAmericaAndCaribbeanPersonalCareBusinessMember2022-03-252022-03-250000916789hele:DistributionAndOfficeFacilitiesElPasoTexasMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-08-310000916789hele:DistributionAndOfficeFacilitiesElPasoTexasMember2023-08-310000916789hele:DistributionAndOfficeFacilitiesElPasoTexasMemberus-gaap:SubsequentEventMember2023-09-280000916789hele:DistributionAndOfficeFacilitiesElPasoTexasMemberus-gaap:SubsequentEventMember2023-09-282023-09-280000916789hele:DistributionAndOfficeFacilitiesElPasoTexasMemberus-gaap:SubsequentEventMember2023-09-012023-11-300000916789hele:DistributionAndOfficeFacilitiesElPasoTexasMemberus-gaap:SubsequentEventMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembersrt:ScenarioForecastMember2023-09-012023-11-300000916789hele:DistributionAndOfficeFacilitiesElPasoTexasMemberus-gaap:SubsequentEventMemberhele:BeautyWellnessMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembersrt:ScenarioForecastMember2023-09-012023-11-300000916789hele:HomeOutdoorMemberhele:DistributionAndOfficeFacilitiesElPasoTexasMemberus-gaap:SubsequentEventMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembersrt:ScenarioForecastMember2023-09-012023-11-300000916789hele:CurlsmithMember2022-04-220000916789hele:CurlsmithMember2022-03-012022-08-310000916789us-gaap:TradeNamesMemberhele:CurlsmithMember2022-04-222022-04-220000916789hele:CurlsmithMemberus-gaap:CustomerRelationshipsMember2022-04-222022-04-220000916789hele:CurlsmithMember2022-03-012023-02-280000916789hele:CurlsmithMember2023-03-012023-05-310000916789us-gaap:TradeNamesMemberhele:CurlsmithMember2022-04-220000916789hele:CurlsmithMemberus-gaap:CustomerRelationshipsMember2022-04-220000916789hele:CurlsmithMember2022-06-012022-08-310000916789us-gaap:RestrictedStockUnitsRSUMember2023-03-012023-05-310000916789us-gaap:RestrictedStockMember2023-03-012023-05-310000916789us-gaap:PerformanceSharesMember2023-03-012023-05-310000916789hele:MarketConditionSharesMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMembersrt:DirectorMember2023-06-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMembersrt:DirectorMember2022-06-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMembersrt:DirectorMember2023-03-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMembersrt:DirectorMember2022-03-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2023-06-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2022-06-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2023-03-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2022-03-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2023-06-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2022-06-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2023-03-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2022-03-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberhele:MarketConditionSharesMember2023-06-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberhele:MarketConditionSharesMember2022-06-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberhele:MarketConditionSharesMember2023-03-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberhele:MarketConditionSharesMember2022-03-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockMember2023-06-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockMember2022-06-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockMember2023-03-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockMember2022-03-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-06-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-06-012022-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-03-012023-08-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-03-012022-08-310000916789us-gaap:RestrictedStockMember2023-08-31xbrli:pure00009167892021-08-3100009167892021-08-252021-08-250000916789hele:OpenMarketAndTenderOfferMember2023-06-012023-08-310000916789hele:OpenMarketAndTenderOfferMember2022-06-012022-08-310000916789hele:OpenMarketAndTenderOfferMember2023-03-012023-08-310000916789hele:OpenMarketAndTenderOfferMember2022-03-012022-08-310000916789us-gaap:StockCompensationPlanMember2023-06-012023-08-310000916789us-gaap:StockCompensationPlanMember2022-06-012022-08-310000916789us-gaap:StockCompensationPlanMember2023-03-012023-08-310000916789us-gaap:StockCompensationPlanMember2022-03-012022-08-310000916789hele:ProjectPegasusMember2023-02-280000916789hele:ProjectPegasusMembersrt:MinimumMember2023-08-310000916789hele:ProjectPegasusMembersrt:MaximumMember2023-08-310000916789hele:ProjectPegasusMemberus-gaap:EmployeeSeveranceMembersrt:MinimumMember2023-08-310000916789hele:ProjectPegasusMemberus-gaap:EmployeeSeveranceMembersrt:MaximumMember2023-08-310000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2023-08-310000916789us-gaap:ContractTerminationMemberhele:ProjectPegasusMember2023-08-310000916789hele:ProjectPegasusMemberus-gaap:OtherRestructuringMembersrt:MinimumMember2023-08-310000916789hele:ProjectPegasusMemberus-gaap:OtherRestructuringMembersrt:MaximumMember2023-08-310000916789hele:HomeOutdoorMemberhele:ProjectPegasusMembersrt:MinimumMember2023-08-310000916789hele:HomeOutdoorMemberhele:ProjectPegasusMembersrt:MaximumMember2023-08-310000916789hele:ProjectPegasusMemberhele:BeautyWellnessMembersrt:MinimumMember2023-08-310000916789hele:ProjectPegasusMemberhele:BeautyWellnessMembersrt:MaximumMember2023-08-310000916789hele:ProjectPegasusMembersrt:MinimumMember2023-06-012023-08-310000916789hele:ProjectPegasusMembersrt:MaximumMember2023-06-012023-08-310000916789hele:RestructuringRecognitionOfSavingsPeriodOneMemberhele:ProjectPegasusMember2023-03-012023-08-310000916789hele:ProjectPegasusMemberhele:RestructuringRecognitionOfSavingsPeriodTwoMember2023-03-012023-08-310000916789hele:ProjectPegasusMemberhele:RestructuringRecognitionOfSavingsPeriodThreeMember2023-03-012023-08-310000916789hele:ProjectPegasusMember2023-06-012023-08-310000916789hele:ProjectPegasusMember2023-03-012023-08-310000916789hele:ProjectPegasusMember2022-06-012022-08-310000916789hele:ProjectPegasusMember2022-03-012022-08-310000916789hele:HomeOutdoorMemberhele:ProjectPegasusMember2023-06-012023-08-310000916789hele:ProjectPegasusMemberhele:BeautyWellnessMember2023-06-012023-08-310000916789hele:HomeOutdoorMemberhele:ProjectPegasusMember2022-06-012022-08-310000916789hele:ProjectPegasusMemberhele:BeautyWellnessMember2022-06-012022-08-310000916789hele:HomeOutdoorMemberhele:ProjectPegasusMember2023-03-012023-08-310000916789hele:ProjectPegasusMemberhele:BeautyWellnessMember2023-03-012023-08-310000916789hele:ProjectPegasusMember2022-06-012023-08-310000916789hele:HomeOutdoorMemberhele:ProjectPegasusMember2022-03-012022-08-310000916789hele:ProjectPegasusMemberhele:BeautyWellnessMember2022-03-012022-08-310000916789hele:ProjectPegasusMemberus-gaap:EmployeeSeveranceMember2023-02-280000916789hele:ProjectPegasusMemberus-gaap:EmployeeSeveranceMember2023-03-012023-08-310000916789hele:ProjectPegasusMemberus-gaap:EmployeeSeveranceMember2023-08-310000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2023-02-280000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2023-03-012023-08-310000916789us-gaap:ContractTerminationMemberhele:ProjectPegasusMember2023-02-280000916789us-gaap:ContractTerminationMemberhele:ProjectPegasusMember2023-03-012023-08-310000916789hele:ProjectPegasusMemberus-gaap:OtherRestructuringMember2023-02-280000916789hele:ProjectPegasusMemberus-gaap:OtherRestructuringMember2023-03-012023-08-310000916789hele:ProjectPegasusMemberus-gaap:OtherRestructuringMember2023-08-310000916789hele:ProjectPegasusMember2023-08-310000916789hele:ProjectPegasusMemberus-gaap:EmployeeSeveranceMember2022-02-280000916789hele:ProjectPegasusMemberus-gaap:EmployeeSeveranceMember2022-03-012022-08-310000916789hele:ProjectPegasusMemberus-gaap:EmployeeSeveranceMember2022-08-310000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2022-02-280000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2022-03-012022-08-310000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2022-08-310000916789us-gaap:ContractTerminationMemberhele:ProjectPegasusMember2022-02-280000916789us-gaap:ContractTerminationMemberhele:ProjectPegasusMember2022-03-012022-08-310000916789us-gaap:ContractTerminationMemberhele:ProjectPegasusMember2022-08-310000916789hele:ProjectPegasusMemberus-gaap:OtherRestructuringMember2022-02-280000916789hele:ProjectPegasusMemberus-gaap:OtherRestructuringMember2022-03-012022-08-310000916789hele:ProjectPegasusMemberus-gaap:OtherRestructuringMember2022-08-310000916789hele:ProjectPegasusMember2022-02-280000916789hele:ProjectPegasusMember2022-08-3100009167892021-12-23hele:renewal0000916789us-gaap:CostOfSalesMemberhele:HealthWellnessMember2023-06-012023-08-310000916789us-gaap:CostOfSalesMemberhele:HealthWellnessMember2022-06-012022-08-310000916789us-gaap:CostOfSalesMemberhele:HealthWellnessMember2023-03-012023-08-310000916789us-gaap:CostOfSalesMemberhele:HealthWellnessMember2022-03-012022-08-310000916789hele:HealthWellnessMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-06-012023-08-310000916789hele:HealthWellnessMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-06-012022-08-310000916789hele:HealthWellnessMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-03-012023-08-310000916789hele:HealthWellnessMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-03-012022-08-310000916789hele:HealthWellnessMember2023-06-012023-08-310000916789hele:HealthWellnessMember2022-06-012022-08-310000916789hele:HealthWellnessMember2023-03-012023-08-310000916789hele:HealthWellnessMember2022-03-012022-08-310000916789us-gaap:CostOfSalesMemberhele:HealthWellnessMemberhele:ObsoletePackagingMember2022-03-012022-05-310000916789hele:WeatherRelatedIncidentMember2022-03-012022-05-3100009167892022-09-012022-11-300000916789hele:CreditAgreementWithBankOfAmericaMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2023-08-310000916789hele:CreditAgreementWithBankOfAmericaMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2023-02-280000916789hele:CreditAgreementWithBankOfAmericaMemberus-gaap:LineOfCreditMemberus-gaap:SecuredDebtMember2023-08-310000916789hele:CreditAgreementWithBankOfAmericaMemberus-gaap:LineOfCreditMemberus-gaap:SecuredDebtMember2023-02-280000916789us-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2023-08-310000916789us-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2023-02-280000916789us-gaap:LineOfCreditMember2023-08-310000916789us-gaap:LineOfCreditMember2023-02-280000916789us-gaap:RevolvingCreditFacilityMember2023-08-310000916789hele:CreditAgreementWithBankOfAmericaMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2023-03-012023-08-310000916789hele:CreditAgreementWithBankOfAmericaMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-06-012022-06-300000916789hele:CreditAgreementWithBankOfAmericaMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-06-300000916789us-gaap:LineOfCreditMemberus-gaap:BaseRateMembersrt:MinimumMember2023-03-012023-08-310000916789us-gaap:LineOfCreditMemberus-gaap:BaseRateMembersrt:MaximumMember2023-03-012023-08-310000916789us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MinimumMember2023-03-012023-08-310000916789us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MaximumMember2023-03-012023-08-310000916789hele:CreditAgreementWithBankOfAmericaMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-03-012023-08-310000916789us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMember2023-08-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-08-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-02-280000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwaptionMember2023-08-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwaptionMember2023-02-280000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-08-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-02-280000916789hele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-06-012023-08-310000916789hele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-03-012023-08-310000916789hele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-06-012022-08-310000916789hele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-03-012022-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-08-31iso4217:EUR0000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:CADus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-31iso4217:CAD0000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:CADus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:CADus-gaap:OtherNoncurrentAssetsMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:CADus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CADus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBPus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-31iso4217:GBP0000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:GBPus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBPus-gaap:OtherNoncurrentAssetsMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMembercurrency:GBPus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBPus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:NOKus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-31iso4217:NOK0000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:NOKus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:NOKus-gaap:OtherNoncurrentAssetsMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:NOKus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:NOKus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:InterestRateSwapMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:InterestRateSwapMember2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMembercurrency:EUR2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:EUR2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMembercurrency:EUR2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMembercurrency:EUR2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMembercurrency:EUR2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMembercurrency:GBP2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:GBP2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMembercurrency:GBP2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMembercurrency:GBP2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMembercurrency:GBP2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2023-08-310000916789us-gaap:NondesignatedMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-08-310000916789us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-08-310000916789us-gaap:OtherNoncurrentAssetsMember2023-08-310000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-08-310000916789us-gaap:OtherNoncurrentLiabilitiesMember2023-08-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:CADus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:CADus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:CADus-gaap:OtherNoncurrentAssetsMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:CADus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CADus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBPus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:GBPus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBPus-gaap:OtherNoncurrentAssetsMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMembercurrency:GBPus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBPus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:NOKus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:NOKus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:NOKus-gaap:OtherNoncurrentAssetsMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMembercurrency:NOKus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:NOKus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:InterestRateSwapMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:InterestRateSwapMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMembercurrency:EUR2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMembercurrency:EURus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMembercurrency:GBP2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-02-280000916789us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-02-280000916789us-gaap:OtherNoncurrentAssetsMember2023-02-280000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMember2023-02-280000916789us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-06-012023-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-06-012022-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2023-06-012023-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2022-06-012022-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2023-06-012023-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-06-012022-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2023-06-012023-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2022-06-012022-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-03-012023-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-03-012022-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2023-03-012023-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2022-03-012022-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2023-03-012023-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-03-012022-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2023-03-012023-08-310000916789us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2022-03-012022-08-310000916789us-gaap:ForwardContractsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-06-012023-08-310000916789us-gaap:ForwardContractsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-06-012022-08-310000916789us-gaap:ForwardContractsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-03-012023-08-310000916789us-gaap:ForwardContractsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-03-012022-08-310000916789us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-06-012023-08-310000916789us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-06-012022-08-310000916789us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-03-012023-08-310000916789us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-03-012022-08-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-02-280000916789us-gaap:AccumulatedTranslationAdjustmentMember2022-02-280000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-03-012022-08-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2022-03-012022-08-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-08-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2022-08-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-02-280000916789us-gaap:AccumulatedTranslationAdjustmentMember2023-02-280000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-012023-08-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2023-03-012023-08-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-08-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2023-08-310000916789hele:HousewaresSegmentMember2023-06-012023-08-310000916789hele:BeautyWellnessMember2023-06-012023-08-310000916789hele:HousewaresSegmentMember2022-06-012022-08-310000916789hele:BeautyWellnessMember2022-06-012022-08-310000916789hele:HousewaresSegmentMember2023-03-012023-08-310000916789hele:BeautyWellnessMember2023-03-012023-08-310000916789hele:HousewaresSegmentMember2022-03-012022-08-310000916789hele:BeautyWellnessMember2022-03-012022-08-310000916789country:US2023-06-012023-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2023-06-012023-08-310000916789country:US2022-06-012022-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2022-06-012022-08-310000916789country:US2023-03-012023-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2023-03-012023-08-310000916789country:US2022-03-012022-08-310000916789us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2022-03-012022-08-310000916789us-gaap:NonUsMember2023-06-012023-08-310000916789us-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-06-012023-08-310000916789us-gaap:NonUsMember2022-06-012022-08-310000916789us-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-06-012022-08-310000916789us-gaap:NonUsMember2023-03-012023-08-310000916789us-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-03-012023-08-310000916789us-gaap:NonUsMember2022-03-012022-08-310000916789us-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2022-03-012022-08-310000916789us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2023-06-012023-08-310000916789us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2022-06-012022-08-310000916789us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2023-03-012023-08-310000916789us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2022-03-012022-08-310000916789us-gaap:EmployeeStockOptionMember2023-06-012023-08-310000916789us-gaap:EmployeeStockOptionMember2022-06-012022-08-310000916789us-gaap:EmployeeStockOptionMember2023-03-012023-08-310000916789us-gaap:EmployeeStockOptionMember2022-03-012022-08-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended August 31, 2023
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __ to __
Commission File Number: 001-14669
helenoftroylogoa15.jpg
HELEN OF TROY LIMITED
(Exact name of registrant as specified in its charter)
Bermuda 74-2692550
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
Clarendon House
2 Church Street
Hamilton, Bermuda
(Address of principal executive offices)
1 Helen of Troy Plaza
El Paso, Texas 79912
(Registrant's United States Mailing Address) (Zip Code)
(915) 225-8000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, $0.10 par value per share HELE The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).       Yes No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of September 28, 2023, there were 23,742,747 common shares, $0.10 par value per share, outstanding.


HELEN OF TROY LIMITED AND SUBSIDIARIES
FORM 10-Q
TABLE OF CONTENTS
  PAGE 
   
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
 
   
   
   
   
   
1

PART I.   FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except shares and par value)August 31, 2023February 28, 2023
Assets  
Assets, current:  
Cash and cash equivalents$24,214 $29,073 
Receivables, less allowances of $5,144 and $1,678
387,498 377,604 
Inventory435,681 455,485 
Prepaid expenses and other current assets28,950 24,721 
Income taxes receivable12,349 5,158 
Total assets, current888,692 892,041 
Property and equipment, net of accumulated depreciation of $156,406 and $178,961
336,349 351,793 
Goodwill1,066,730 1,066,479 
Other intangible assets, net of accumulated amortization of $177,825 and $168,574
544,958 553,883 
Operating lease assets37,555 38,751 
Deferred tax assets, net2,996 2,781 
Assets held for sale
17,179  
Other assets7,201 7,987 
Total assets$2,901,660 $2,913,715 
Liabilities and Stockholders' Equity  
Liabilities, current:  
Accounts payable$258,669 $190,598 
Accrued expenses and other current liabilities195,359 200,718 
Income taxes payable12,132 14,778 
Long-term debt, current maturities6,235 6,064 
Total liabilities, current472,395 412,158 
Long-term debt, excluding current maturities838,668 928,348 
Lease liabilities, non-current41,036 42,672 
Deferred tax liabilities, net34,747 28,048 
Other liabilities, non-current12,931 13,678 
Total liabilities1,399,777 1,424,904 
Commitments and contingencies
Stockholders' equity:  
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued
  
Common stock, $0.10 par. Authorized 50,000,000 shares; 23,719,204 and 23,994,405 shares issued and outstanding
2,372 2,399 
Additional paid in capital 330,227 317,277 
Accumulated other comprehensive income
3,686 4,947 
Retained earnings1,165,598 1,164,188 
Total stockholders' equity1,501,883 1,488,811 
Total liabilities and stockholders' equity$2,901,660 $2,913,715 

See accompanying notes to condensed consolidated financial statements.
2

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Income (Unaudited) 

 Three Months Ended August 31,Six Months Ended August 31,
(in thousands, except per share data)2023202220232022
Sales revenue, net$491,563 $521,400 $966,235 $1,029,478 
Cost of goods sold261,910 299,954 520,951 596,861 
Gross profit229,653 221,446 445,284 432,617 
Selling, general and administrative expense (“SG&A”)
179,191 169,724 346,826 346,954 
Restructuring charges3,617 4,776 10,972 4,778 
Operating income46,845 46,946 87,486 80,885 
Non-operating income, net148 113 285 180 
Interest expense13,654 9,166 27,706 13,539 
Income before income tax33,339 37,893 60,065 67,526 
Income tax expense5,958 7,221 10,103 12,259 
Net income$27,381 $30,672 $49,962 $55,267 
Earnings per share (“EPS”):
  
Basic$1.14 $1.28 $2.08 $2.31 
Diluted 1.14 1.28 2.07 2.29 
Weighted average shares used in computing EPS:  
Basic23,918 23,969 23,984 23,917 
Diluted24,041 24,056 24,088 24,089 

See accompanying notes to condensed consolidated financial statements.
3

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income (Unaudited) 

 Three Months Ended August 31,Six Months Ended August 31,
(in thousands)2023202220232022
Net income$27,381 $30,672 $49,962 $55,267 
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps2,768 1,301 (324)3,507 
Cash flow hedge activity - foreign currency contracts(314)2,538 (937)3,491 
Total other comprehensive income (loss), net of tax
2,454 3,839 (1,261)6,998 
Comprehensive income$29,835 $34,511 $48,701 $62,265 

See accompanying notes to condensed consolidated financial statements.
4

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

Common StockAdditional Paid in CapitalAccumulated Other Comprehensive IncomeRetained EarningsTotal Stockholders' Equity
(in thousands, including shares) SharesPar
Value
Balances at February 28, 202223,800 $2,380 $303,740 $202 $1,021,017 $1,327,339 
Net income— — — — 24,595 24,595 
Other comprehensive income, net of tax— — — 3,159 — 3,159 
Exercise of stock options8 1 658 — — 659 
Issuance and settlement of restricted stock235 24 (24)— —  
Issuance of common stock related to stock purchase plan13 1 2,274 — — 2,275 
Common stock repurchased and retired(89)(9)(18,113)— (102)(18,224)
Share-based compensation— — 16,619 — — 16,619 
Balances at May 31, 202223,967 $2,397 $305,154 $3,361 $1,045,510 $1,356,422 
Net income— — — — 30,672 30,672 
Other comprehensive income, net of tax— — — 3,839 — 3,839 
Issuance and settlement of restricted stock2 — (1)— — (1)
Common stock repurchased and retired— — (81)— — (81)
Share-based compensation— — 7,495 — — 7,495 
Balances at August 31, 202223,969 $2,397 $312,567 $7,200 $1,076,182 $1,398,346 

Balances at February 28, 202323,994 $2,399 $317,277 $4,947 $1,164,188 $1,488,811 
Net income    22,581 22,581 
Other comprehensive loss, net of tax   (3,715) (3,715)
Exercise of stock options5 1 211   212 
Issuance and settlement of restricted stock120 12 (12)   
Issuance of common stock related to stock purchase plan23 2 2,166   2,168 
Common stock repurchased and retired(45)(4)(4,442)  (4,446)
Share-based compensation  9,297   9,297 
Balances at May 31, 202324,097 $2,410 $324,497 $1,232 $1,186,769 $1,514,908 
Net income    27,381 27,381 
Other comprehensive income, net of tax   2,454  2,454 
Issuance and settlement of restricted stock4      
Common stock repurchased and retired(382)(38)(1,499) (48,552)(50,089)
Share-based compensation  7,229   7,229 
Balances at August 31, 202323,719 $2,372 $330,227 $3,686 $1,165,598 $1,501,883 

See accompanying notes to condensed consolidated financial statements.



5

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)
 Six Months Ended August 31,
(in thousands)20232022
Cash provided (used) by operating activities:  
Net income$49,962 $55,267 
Adjustments to reconcile net income to net cash provided (used) by operating activities:  
Depreciation and amortization24,606 21,617 
Amortization of financing costs616 512 
Non-cash operating lease expense3,941 5,186 
Provision for credit losses 3,671 963 
Non-cash share-based compensation16,526 24,114 
Gain on sale of Personal Care business (1,336)
Gain on the sale or disposal of property and equipment(246)(20)
Deferred income taxes and tax credits6,845 3,977 
Changes in operating capital, net of effects of acquisitions of businesses:  
Receivables(14,427)(46,754)
Inventory19,804 (77,348)
Prepaid expenses and other current assets(5,391)575 
Other assets and liabilities, net(253)(2,040)
Accounts payable71,990 3,333 
Accrued expenses and other current liabilities(10,317)(43,767)
Accrued income taxes(9,595)(19,731)
Net cash provided (used) by operating activities
157,732 (75,452)
Cash used by investing activities:  
Capital and intangible asset expenditures(20,557)(112,635)
Net payments to acquire businesses, net of cash acquired (148,111)
Proceeds from sale of Personal Care business 1,804 
Proceeds from the sale of property and equipment246 20 
Net cash used by investing activities
(20,311)(258,922)
Cash (used) provided by financing activities:  
Proceeds from revolving loans261,150 573,500 
Repayment of revolving loans(348,150)(465,000)
Proceeds from term loans 250,000 
Repayment of long-term debt
(3,125)(1,900)
Payment of financing costs (586)
Proceeds from share issuances under share-based compensation plans2,380 2,934 
Payments for repurchases of common stock(54,535)(18,305)
Net cash (used) provided by financing activities(142,280)340,643 
Net (decrease) increase in cash and cash equivalents
(4,859)6,269 
Cash and cash equivalents, beginning balance29,073 33,381 
Cash and cash equivalents, ending balance$24,214 $39,650 
Supplemental non-cash investing activity:
Capital expenditures included in accounts payable$2,790 $8,484 

See accompanying notes to condensed consolidated financial statements.
6

HELEN OF TROY LIMITED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
August 31, 2023

Note 1 - Basis of Presentation and Related Information

Corporate Overview

The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of August 31, 2023 and February 28, 2023, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2023 (“Form 10-K”), and our other reports on file with the Securities and Exchange Commission (the “SEC”).

When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to accounting principles generally accepted in the United States of America (the “U.S.”). References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. As of August 31, 2023, we operated two reportable segments: Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan (as further described below and in Note 8) that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our Chief Executive Officer (“CEO”), our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes nor to the way in which our CEO assesses performance and allocates resources for the Home & Outdoor segment. As a result of these changes, our disclosures reflect two reportable segments, Home & Outdoor and Beauty & Wellness. Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. Our external reportable segments will continue to align with our internal reporting to enable users of the financial statements to better understand our performance, better assess our future net cash flows, and make more informed judgments about the Company as a whole.

Our Home & Outdoor segment provides a broad range of outstanding world-class brands that help consumers enjoy an outdoor lifestyle and make everyday living better. Our innovative products for home activities include food preparation, cooking, cleaning, organization, and beverage service. Our outdoor performance range includes hydration products, backpacks, and travel gear to ease your journey and inspire your next adventure. The Beauty & Wellness segment provides consumers with a broad range of
7

outstanding world-class brands for beauty and wellness. In Beauty, we deliver innovation through products such as hair styling appliances, grooming tools, and liquid-, solid-, and powder-based personal care products that help make everyone look and feel more beautiful. On the Wellness side, we are there when you need us most with highly regarded humidifiers, thermometers, water and air purifiers, heaters, and fans.

Our business is seasonal due to different calendar events, holidays and seasonal weather and illness patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico, Vietnam and the U.S.

During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). See Note 8 for additional information.

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment and cash acquired. The Curlsmith brand and products were added to the Beauty & Wellness segment. See Note 4 for additional information.

During fiscal 2022 and fiscal 2023, we divested certain assets within our Beauty & Wellness segment's mass channel personal care business, which included liquid, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium (“Personal Care”). On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million.

Principles of Consolidation

The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation.

The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

Reclassifications

We have reclassified or combined certain amounts in the prior year's accompanying footnotes to conform with the current year's presentation.

Note 2 - New Accounting Pronouncements

Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K.



8

Adopted

In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations, which requires a buyer in a supplier finance program to disclose qualitative and quantitative information about its program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in ASU 2022-04 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with the exception for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The guidance should be applied retrospectively, except for the amendment on rollforward information, which should be applied prospectively. This ASU was effective for us in the first quarter of fiscal 2024, with the exception of the amendment on rollforward information, which will be effective for us in our Form 10-K for fiscal 2025. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statement disclosures.

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Prior to the issuance of this guidance, contract assets and contract liabilities were recognized by the acquirer at fair value on the acquisition date. The amendments in ASU 2021-08 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, and should be applied prospectively to acquisitions occurring on or after the effective date. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statements.

Note 3 - Assets Held for Sale

On August 29, 2023, we entered into an agreement to sell our distribution and office facilities in El Paso, Texas, which provides for closing subsequent to a due diligence period. Accordingly, we classified the associated property and equipment totaling $17.2 million, net of accumulated depreciation of $36.8 million, as held for sale as of August 31, 2023.

Subsequent to the end of our second quarter of fiscal 2024, on September 28, 2023, we completed the sale of our distribution and office facilities in El Paso, Texas for a sales price of $50.6 million, less transaction costs of $1.1 million. Concurrently, we entered into an agreement to leaseback the office facilities for a period of up to 18 months substantially rent free, which we estimate to have a fair value of approximately $1.9 million. The transaction qualifies for sales recognition under the sale leaseback accounting requirements. Accordingly, we increased the sales price by the $1.9 million of prepaid rent and expect to recognize a gain on the sale of approximately $34.2 million within SG&A during the third quarter of fiscal year 2024, of which approximately $18.0 million and $16.2 million will be recognized by our Beauty & Wellness and Home & Outdoor segments, respectively. The related assets will be derecognized from the consolidated balance sheet, and at lease commencement, we will record an operating lease asset, which includes the imputed rent payments described above, and an operating lease liability. We plan to use the proceeds from the sale to repay amounts outstanding under our long-term debt agreement.

9

Note 4 - Acquisition of Curlsmith

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand. Curlsmith's products are a category leader in the market for prestige haircare products for curly hair and include conditioners, shampoos and co-washes purposefully designed for the unique joys and challenges of all types of curls and textured hair. The Curlsmith brand and products were added to the Beauty & Wellness segment. The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment of $2.1 million and cash acquired. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $2.7 million during the six months ended August 31, 2022, which were recognized in SG&A within our condensed consolidated statement of income.

We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our Beauty & Wellness segment's existing marketing and sales structure, as well as our global sourcing, distribution, shared service, and international go-to-market capabilities. The goodwill is not expected to be deductible for income tax purposes. We have determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $21.0 million to trade names and are amortizing over a 20 year expected life. We assigned $12.0 million to customer relationships and are amortizing over a 19.5 year expected life, based on historical attrition rates.

During fiscal 2023, we made adjustments to provisional asset and liability balances, which resulted in a corresponding net increase to goodwill of $0.1 million. We also finalized the net working capital adjustment during fiscal 2023, which resulted in a $1.8 million reduction to the total purchase consideration and goodwill. During the first quarter of fiscal 2024, we made final adjustments to provisional liability balances, which resulted in a corresponding increase to goodwill of $0.3 million.

The following table presents the estimated fair values of assets acquired and liabilities assumed at the acquisition date:
 (in thousands)
Assets: 
Receivables$4,211 
Inventory7,890 
Prepaid expenses and other current assets119 
Property and equipment212 
Goodwill117,108 
Trade names - definite21,000 
Customer relationships - definite12,000 
Deferred tax assets, net360 
Total assets162,900 
Liabilities:
Accounts payable1,401 
Accrued expenses and other current liabilities2,813 
Income taxes payable2,572 
Deferred tax liabilities, net8,187 
Total liabilities14,973 
Net assets recorded$147,927 

10

Both the fair value and gross contractual amount of receivables acquired was $4.2 million, as an immaterial amount was expected to be uncollectible.

The impact of the acquisition of Curlsmith on our condensed consolidated statements of income for the periods presented was as follows:

(in thousands, except earnings per share data)
Three Months Ended August 31, 2022 (1)
Six Months Ended
August 31, 2022 (1) (2)
Sales revenue, net$10,207 $13,453 
Net income1,437 1,876 
EPS:
Basic$0.06 $0.08 
Diluted$0.06 $0.08 

(1)Net income and EPS amounts include allocations for corporate expenses, interest expense and income tax expense.
(2)Represents approximately nineteen weeks of operating results from Curlsmith, acquired April 22, 2022.

The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and does not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results.
(in thousands, except earnings per share data)Three Months Ended August 31, 2022Six Months Ended
August 31, 2022
Sales revenue, net$521,400 $1,036,570 
Net income30,672 57,180 
EPS:
Basic$1.28 $2.39 
Diluted$1.28 $2.37 

These amounts have been calculated after applying our accounting policies and adjusting the results of Curlsmith to reflect the effect of definite-lived intangible assets recognized as part of the business combination on amortization expense as if the acquisition had occurred on March 1, 2021.

Note 5 - Accrued Expenses and Other Current Liabilities

A summary of accrued expenses and other current liabilities was as follows:
(in thousands)August 31, 2023February 28, 2023
Accrued compensation, benefits and payroll taxes$31,947 $17,380 
Accrued sales discounts and allowances48,908 63,881 
Accrued sales returns23,240 28,498 
Accrued advertising35,112 36,931 
Other56,152 54,028 
Total accrued expenses and other current liabilities$195,359 $200,718 

Note 6 - Share-Based Compensation Plans

As part of our compensation structure, we grant share-based compensation awards to certain employees and non-employee members of our Board of Directors during the fiscal year. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions.
11

During the first quarter of fiscal 2024, we granted 94,807 service condition awards (“Service Condition Awards”) with a weighted average grant date fair value of $110.85. Additionally, we granted 252,522 performance-based awards during the first quarter of fiscal 2024, of which 126,318 contained performance conditions (“Performance Condition Awards”) and 126,204 contained market conditions (“Market Condition Awards”), with weighted average grant date fair values of $110.85 and $80.50, respectively. Refer to our Form 10-K for further information on the Company's share-based compensation plans.

We recorded share-based compensation expense in SG&A as follows:
 Three Months Ended August 31,Six Months Ended
August 31,
(in thousands)2023202220232022
Directors stock compensation$196 $222 $393 $395 
Service Condition Awards2,878 2,160 6,198 5,277 
Performance Condition Awards1,113 3,196 3,136 14,041 
Market Condition Awards3,042 1,917 6,189 3,827 
Employee stock purchase plan  610 574 
Share-based compensation expense7,229 7,495 16,526 24,114 
Less income tax benefits(385)(570)(1,026)(1,654)
Share-based compensation expense, net of income tax benefits$6,844 $6,925 $15,500 $22,460 

Unrecognized Share-Based Compensation Expense

As of August 31, 2023, our total unrecognized share-based compensation for all awards was $32.9 million, which will be recognized over a weighted average amortization period of 2.0 years. The total unrecognized share-based compensation reflects an estimate of target achievement for Performance Condition Awards granted during the first quarter of fiscal 2024, and an estimate of zero percent of target achievement for Performance Condition Awards granted in fiscal 2023 and fiscal 2022.

Note 7 - Repurchases of Common Stock

In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. As of August 31, 2023, our repurchase authorization allowed for the purchase of $349.1 million of common stock.

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares.

12

The following table summarizes our share repurchase activity for the periods shown:
 Three Months Ended August 31,Six Months Ended August 31,
(in thousands, except share and per share data)2023202220232022
Common stock repurchased on the open market: 
Number of shares381,200  381,200  
Aggregate value of shares$50,006 $ $50,006 $ 
Average price per share$131.18 $ $131.18 $ 
Common stock received in connection with share-based compensation:
Number of shares765 501 45,397 89,959 
Aggregate value of shares$83 $81 $4,529 $18,305 
Average price per share$108.00 $163.28 $99.75 $203.49 

Note 8 - Restructuring Plan

During the second quarter of fiscal 2023, we focused on developing Project Pegasus, a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs. Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments.

During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with Project Pegasus that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our CEO, our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes.

As part of our initiative focused on streamlining and simplifying the organization, we made further changes to the structure of our organization, during the fourth quarter of fiscal 2023, which include the creation of a North America Regional Market Organization (“RMO”) responsible for sales and go to market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services, particularly in operations and finance to better support our business segments and RMOs. This new structure, inclusive of the organizational structure changes described above resulting in the reportable segment change, will reduce the size of our global workforce by approximately 10%. The majority of these role reductions were completed by March 1, 2023. We believe that these changes better focus business segment resources on brand development, consumer-centric innovation and marketing, the RMOs on sales and go to market strategies, and shared services on their respective areas of expertise while also creating a more efficient and effective organizational structure.

During the second quarter of fiscal 2024, we announced plans to geographically consolidate the U.S. Beauty business, currently located in El Paso, Texas, and Irvine, California, and co-locate it with our Wellness business in the Boston, Massachusetts area. This geographical consolidation and relocation is the next step in our initiative to streamline and simplify the organization and it is expected to be
13

completed during fiscal 2025. We expect these changes will enable a greater opportunity to capture synergies and enhance collaboration and innovation within the Beauty & Wellness segment.

We have updated our expectations regarding Project Pegasus charges. We now estimate lower total one-time pre-tax restructuring charges of approximately $60 million to $65 million over the duration of the plan. We now expect these charges to be completed during fiscal 2025. We previously had estimated total pre-tax restructuring charges of approximately $85 million to $95 million, which was initially expected to be substantially completed by the end of fiscal 2024. In addition, we now have the following expectations regarding Project Pegasus charges:
Pre-tax restructuring charges to be comprised of approximately $22 million to $25 million of severance and employee related costs, $30 million of professional fees, $5 million of contract termination costs, and $3 million to $5 million of other exit and disposal costs.
All of our operating segments and shared services will be impacted by the plan and pre-tax restructuring charges include approximately $17 million to $19 million in Home & Outdoor and $43 million to $46 million in Beauty & Wellness.
Pre-tax restructuring charges represent primarily cash expenditures, which are expected to be substantially paid by the end of fiscal 2025.

We continue to have the following expectations regarding Project Pegasus savings:
Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which we expect to substantially begin in fiscal 2024 and be substantially achieved by the end of fiscal 2026.
Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026.
Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.

During the three and six month periods ended August 31, 2023, we incurred $3.6 million and $11.0 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statement of income. We recognized $4.8 million of pre-tax restructuring costs during both the three and six month periods ended August 31, 2022 in connection with Project Pegasus.

The following tables summarize restructuring charges recorded as a result of Project Pegasus for the periods presented:
Three Months Ended August 31, 2023
(in thousands)Home &
Outdoor
Beauty &
Wellness
Total
Severance and employee related costs$87 $501 $588 
Professional fees1,182 1,719 2,901 
Contract termination 108 108 
Other2 18 20 
Total restructuring charges$1,271 $2,346 $3,617 

Three Months Ended August 31, 2022
(in thousands)Home &
Outdoor
Beauty &
Wellness
Total
Severance and employee related costs$472 $2,369 $2,841 
Professional fees 128 128 
Contract termination 1,500 1,500 
Other 307 307 
Total restructuring charges$472 $4,304 $4,776 
14

 Six Months Ended August 31, 2023Total
Incurred Since Inception
(in thousands)Home &
Outdoor
Beauty & WellnessTotal
Severance and employee related costs$571 $909 $1,480 $10,933 
Professional fees3,451 5,076 8,527 25,276 
Contract termination 796 796 1,331 
Other39 130 169 794 
Total restructuring charges$4,061 $6,911 $10,972 $38,334 

 Six Months Ended August 31, 2022
(in thousands)Home &
Outdoor
Beauty &
Wellness
Total
Severance and employee related costs$472 $2,371 $2,843 
Professional fees 128 128 
Contract termination 1,500 1,500 
Other 307 307 
Total restructuring charges$472 $4,306 $4,778 

The tables below present a rollforward of our accruals related to Project Pegasus, which are included in accounts payable and accrued expenses and other current liabilities:
(in thousands)Balance at February 28, 2023ChargesPaymentsBalance at August 31, 2023
Severance and employee related costs$3,173 $1,480 $(3,422)$1,231 
Professional fees3,201 8,527 (10,635)1,093 
Contract termination160 796 (956) 
Other34 169 (203) 
Total$6,568 $10,972 $(15,216)$2,324 

(in thousands)Balance at February 28, 2022ChargesPaymentsBalance at August 31, 2022
Severance and employee related costs$ $2,843 $(802)$2,041 
Professional fees 128 (128) 
Contract termination 1,500  1,500 
Other 307 (307) 
Total$ $4,778 $(1,237)$3,541 

Note 9 - Commitments and Contingencies

Legal Matters

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below.

On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. In the Patent Litigation, Brita LP seeks monetary damages and injunctive relief relating to the alleged infringement. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. In the ITC Action, Brita LP requested the ITC to initiate an unfair import investigation relating to such filtration systems. This
15

action seeks injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory that is already in the U.S. On January 25, 2022, the ITC instituted the investigation requested by the ITC Action. Discovery closed in the ITC Action in May 2022, and approximately half of the originally identified PUR gravity-fed water filters were removed from the case and are no longer included in the ITC Action. In August 2022, the parties participated in the evidentiary hearing, with additional supplemental hearings in October 2022. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against Kaz USA, Inc. and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including Kaz USA, Inc., filed a petition with the ITC for a full review of the Initial Determination. On September 19, 2023, the ITC issued its Final Determination in the Company’s favor. The ITC determined there was no violation by the Company and terminated the investigation. The Patent Litigation remains stayed for the time being, but we believe the stay will be lifted in the near future. We cannot predict the outcome of these legal proceedings, the amount or range of any potential loss, when the proceedings will be resolved, or customer acceptance of any replacement water filter. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations.

Regulatory Matters

Our operations are subject to national, state, local, and provincial jurisdictions’ environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification, labeling and claim requirements. Some product lines within our Beauty & Wellness segment are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission.

During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. We resumed normalized levels of shipping of the affected inventory during fiscal 2022 and we completed the repackaging of our existing inventory of impacted products during fiscal 2023. Additionally, as a result of continuing dialogue with the EPA, we executed further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products, which were also completed during fiscal 2023. Although we are not aware of any fines or penalties related to this matter imposed against us by the EPA at this time, there can be no assurances that such fines or penalties will not be imposed in the future.

We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.”

16

The following table provides a summary of EPA compliance costs incurred during the periods presented:

Three Months Ended August 31,Six Months Ended August 31,
(in thousands)2023202220232022
Cost of goods sold$ $7,103 $ $16,558 
1
SG&A 1,251  3,440 
Total EPA compliance costs$ $8,354 $ $19,998 
(1)Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.
In addition, we incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products beginning in the second quarter of fiscal 2022 through completion of the repackaging in the third quarter of fiscal 2023. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs”.

Weather-Related Incident

On March 30, 2022, a third-party facility that we utilized for inventory storage incurred severe damage from a weather-related incident. The inventory that was stored at this facility primarily related to our Beauty & Wellness segment. While the inventory was insured, some seasonal inventory and inventory designated for specific customer promotions was not accessible and subsequently determined to be damaged, and as a result, unfavorably impacted our net sales revenue during the first quarter of fiscal 2023. As a result of the damages to the inventory stored at the facility, we recorded a charge to write-off the damaged inventory totaling $34.4 million during the first quarter of fiscal 2023. These charges were fully offset by probable insurance recoveries of $34.4 million also recorded during the first quarter of fiscal 2023, which represented anticipated insurance proceeds, not to exceed the amount of the associated losses, for which receipt was deemed probable. The charges for the damaged inventory and the expected insurance recoveries are included in cost of goods sold in our condensed consolidated statement of income for the six months ended August 31, 2022. During the third and fourth quarters of fiscal 2023, we received proceeds totaling $46.0 million from our insurance carriers related to this incident, which were included in cash flows from operating activities in our condensed consolidated statements of cash flows. As a result, during the third quarter of fiscal 2023, the Company recorded a gain of $9.7 million, net of costs incurred to dispose of the inventory, as a reduction of SG&A expense in our condensed consolidated statement of income.

17

Note 10 - Long-Term Debt
A summary of our long-term debt follows:
(in thousands)August 31, 2023February 28, 2023
Credit Agreement (1):
Revolving loans603,000 690,000 
Term loans243,750 246,875 
Total borrowings under Credit Agreement846,750 936,875 
Unamortized prepaid financing fees(1,847)(2,463)
Total long-term debt844,903 934,412 
Less: current maturities of long-term debt(6,235)(6,064)
Long-term debt, excluding current maturities$838,668 $928,348 
(1)The weighted average interest rates on borrowings outstanding under the Credit Agreement (defined below) as of August 31, 2023 and February 28, 2023 were 7.1% and 6.6%, respectively.

Capitalized Interest

During the three month period ended August 31, 2023, we incurred interest costs totaling $13.7 million, of which none was capitalized, compared to $10.1 million for the same period last year, of which we capitalized $0.9 million as part of property and equipment in connection with the construction of a new distribution facility. During the six month periods ended August 31, 2023 and August 31, 2022, we incurred interest costs totaling $28.6 million and $15.2 million, respectively, of which we capitalized $0.9 million and $1.6 million, respectively, in connection with the previously mentioned distribution facility.

Credit Agreement

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and a $300 million accordion, which can be used for term loan commitments. In June 2022, we exercised $250 million of the $300 million accordion under the Credit Agreement and borrowed $250 million as term loans. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% of the term loans made, which began in the third quarter of fiscal 2023, with the remaining balance due at the maturity date. The maturity date of the term loans and the revolving loans under the Credit Agreement is March 13, 2025. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings.

The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $625 million and $425 million of the outstanding principal balance under the revolving loans as of August 31, 2023 and February 28, 2023, respectively. See Notes 11, 12, and 13 for additional information regarding our interest rate swaps.

As of August 31, 2023, the balance of outstanding letters of credit was $17.8 million and the amount available for revolving loans under the Credit Agreement was $629.2 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As of August 31, 2023, these covenants effectively limited our ability to incur more than $231.1 million of additional debt from all sources, including the Credit Agreement, or $465.8 million in the event a qualified acquisition is consummated.

18

Debt Covenants

As of August 31, 2023, we were in compliance with all covenants as defined under the terms of the Credit Agreement.

Note 11 - Fair Value 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy:

Level 1:Quoted prices for identical assets or liabilities in active markets;

Level 2:Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and

Level 3:Unobservable inputs that reflect the reporting entity’s own assumptions.

Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2:
 Carrying Amount and Fair Value
(in thousands)August 31, 2023February 28, 2023
Assets: 
Cash equivalents (money market accounts)$469 $381 
Interest rate swaps5,322 5,746 
Foreign currency derivatives617 1,423 
Total assets$6,408 $7,550 
  
Liabilities: 
Foreign currency derivatives1,153 711 
Total liabilities$1,153 $711 

The carrying amounts of cash, accounts payable, accrued expenses and other current liabilities and income taxes payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value.

We use derivatives to manage our exposure to changes in foreign currency exchange rates, which include foreign currency forward contracts and cross-currency debt swaps. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 12 and 13 for more information on our derivatives.

19

Note 12 - Financial Instruments and Risk Management

Foreign Currency Risk

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. Approximately 12% and 14% of our net sales revenue was denominated in foreign currencies during the three and six month periods ended August 31, 2023, respectively, compared to 12% for both of the same periods last year. These sales were primarily denominated in Euros, British Pounds and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases.

During the three and six month periods ended August 31, 2023, we recorded foreign currency exchange rate net losses of $0.8 million and $0.4 million, respectively, in SG&A, compared to net losses of $2.7 million and $2.5 million, respectively, for the same periods last year. We mitigate certain foreign currency exchange rate risk by using forward contracts and cross-currency debt swaps to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges (“foreign currency contracts”) and are recorded on the balance sheet at fair value with changes in fair value recorded in Other Comprehensive Income (Loss) (“OCI”) until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive Income (Loss) (“AOCI”) to our condensed consolidated statements of income. Foreign currency derivatives for which we have not elected hedge accounting consist of certain forward contracts and cross-currency debt swaps, and any changes in the fair value of these derivatives are recorded in our condensed consolidated statements of income. These undesignated derivatives are used to hedge monetary net asset and liability positions. Cash flows from our foreign currency derivatives are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

Interest Rate Risk

Interest on our outstanding debt as of August 31, 2023 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on a portion of our outstanding principal balance under the Credit Agreement, which totaled $846.8 million and $936.9 million as of August 31, 2023 and February 28, 2023, respectively. As of August 31, 2023 and February 28, 2023, $625.0 million and $425.0 million of the outstanding principal balance under the Credit Agreement, respectively, was hedged with interest rate swaps to fix the interest rate we pay. Our interest rate swaps are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in OCI until the hedge transaction is settled, at which point amounts are reclassified from AOCI to our condensed consolidated statements of income. Cash flows from our interest rate swaps are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

20

The following tables summarize the fair values of our derivative instruments as of the end of the periods presented:
(in thousands)August 31, 2023

Derivatives designated as hedging instruments
Hedge
Type
Final
Settlement Date
Notional AmountPrepaid
Expenses
and Other
Current Assets
Other AssetsAccrued
Expenses
and Other
Current Liabilities
Other
Liabilities, Non- Current
Forward contracts - sell EuroCash flow2/202421,500 $67 $ $165 $ 
Forward contracts - sell Canadian DollarsCash flow12/2024$25,250 370 77   
Forward contracts - sell PoundsCash flow2/2024£20,925   949  
Forward contracts - sell Norwegian KronerCash flow2/2024kr20,000 103    
Interest rate swapsCash flow2/2026$625,000 3,582 1,740   
Subtotal   4,122 1,817 1,114  
Derivatives not designated under hedge accounting       
Forward contracts - buy Euro(1)9/20232,200   33  
Forward contracts - buy Pounds(1)9/2023£1,100   6  
Subtotal     39  
Total fair value$4,122 $1,817 $1,153 $